Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-26

FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Clozapine from Teva Pharmaceuticals USA, Inc., updating its labeling to reflect new information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)